Search All UT System Experts

A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas

Quincy S C Chu, Bahram Forouzesh, Samira Syed, Monica Mita, Garry Schwartz, Joshua Copper, Janet Curtright, Eric K. Rowinsky

Research output: Contribution to journal › Article › peer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas'. Together they form a unique fingerprint.

Medicine & Life Sciences